VIVS
VIVS
NASDAQ · Biotechnology

Vivosim Labs Inc

$1.32
+0.02 (+1.54%)
As of May 16, 2:32 AM ET ·
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +2,068.9% upside
Low Target $25.08
Average Target $28.63
High Target $44.18
Current Price $1.32
Current
$1.32
Target
$28.63
$25.08 $28.63 avg $44.18
Scenario Analysis
Bear Case
$25.08
1,800.0%
Low target
Base Case
$28.63
+2,068.9%
Avg target
Bull Case
$44.18
+3,247.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$5.30
-75.1% from high
52-Week Low
$1.25
+5.6% from low
Target vs 52W High
$28.63
+440.2% vs high
Next Earnings Report
Jun 3, 2026 · Before Market Open
17d
until earnings
EPS Est: $-0.19
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
Buy 43 56% $91.45 -52.6%